Pulmonx Corp
NASDAQ:LUNG
Pulmonx Corp
NASDAQ:LUNG
Price:
9.53 USD
2.69%
Market Closed
Updated:
May 8, 2024
Pulmonx Corp
Operating Expenses
|
Pulmonx Corp
Operating Expenses Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pulmonx Corp
NASDAQ:LUNG
|
Operating Expenses
-$112.7m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Cooper Companies Inc
NYSE:COO
|
Operating Expenses
-$1.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Operating Expenses
-$1.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Operating Expenses
-$2.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-20%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Operating Expenses
-$399.9m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-17%
|
See Also
What is Pulmonx Corp's Operating Expenses?
Operating Expenses
-112.7m
USD
-112.7m
USD
Based on the financial report for Dec 31, 2023, Pulmonx Corp's Operating Expenses amounts to -112.7m USD.
What is Pulmonx Corp's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-33%
-33%
Over the last year, the Operating Expenses growth was -14%. The average annual Operating Expenses growth rates for Pulmonx Corp have been -28% over the past three years , -33% over the past five years .
You don't have any saved screeners yet
